The Evolving Treatment Paradigm for Platinum-Resistant Ovarian Cancer

Floortje J Backes, MD, discusses evolving treatment considerations for platinum-resistant ovarian cancer.

EP. 1: Current Treatment Considerations for Platinum-Resistant Ovarian Cancer

February 6th 2025

Floortje J Backes, MD, discusses current treatment considerations for platinum-resistant ovarian cancer.

EP. 2: How Mirvetuximab Soravtansine Has Impacted Clinical Management of Ovarian Cancer

February 6th 2025

Floortje J Backes, MD, discusses how mirvetuximab soravtansine has affected the management of platinum-resistant ovarian cancer.

EP. 3: Testing for FRα in Ovarian Cancer

February 6th 2025

Floortje J. Backes, MD, discusses how to approach FRα testing in ovarian cancer.

EP. 4: PICCOLO Data for Mirvetuximab Soravtansine in FRα+, Platinum-Sensitive Ovarian Cancer

February 6th 2025

Floortje J. Backes, MD, discusses data for mirvetuximab soravtansine in FRα-positive, platinum-sensitive ovarian cancer

EP. 5: Additional Potential Roles for Mirvetuximab Soravtansine and Other ADCs in Ovarian Cancer

February 6th 2025

Floortje J. Backes, MD, discusses other potential roles for mirvetuximab soravtansine and other antibody-drug conjugates in ovarian cancer.

EP. 6: Ongoing Research to Watch in Ovarian Cancer

February 6th 2025

Floortje J. Backes, MD, discusses ongoing research to watch in ovarian cancer.